Triamcinolone acetonide - HY-B0636
10mM
Nicht lieferbar
Nur noch %1 verfügbar
Catalog #
HY-B0636
Triamcinolone acetonide inhibits basic fibroblast growth factor (bFGF) induced proliferation of retinal endothelial cells. Triamcinolone acetonide reduces chondrocyte viability and leads to cartilage destruction. Triamcinolone acetonide activates macrophage with anti-inflammatory characteristics. Triamcinolone acetonide can be used in the study of diseases such as atopic dermatitis[1][2][3][4].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B0636/Triamcinolone-acetonide-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| CAS | 76-25-5 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 434.50 |
| Solubility | DMSO : 50 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL |
| Clinical Information | Launched |
| Target | FGFR;Glucocorticoid Receptor |
| Application: | COVID-19-immunoregulation |
|---|